| Structure |
Chemical Name |
CAS |
MF |
 |
Apremilast Impurity F |
|
|
|
|
Apremilast Impurity C |
|
|
 |
Apremilast |
1384440-16-7 |
C19H20N2O6S |
 |
5-(1-amino-2-(methylsulfonyl)ethyl)-2-methoxyphenol |
2169153-70-0 |
C10H15NO4S |
 |
INDEX NAME NOT YET ASSIGNED |
2417213-74-0 |
C42H42N4O12S |
|
|
Apremilast Impurity 999 |
|
|
 |
5-クロロチオフェン-2-カルボン酸メチル |
35475-03-7 |
C6H5ClO2S |
|
|
Apixaban IMpurity(BMS-778960-01) |
|
|
|
|
Apremilast Impurity 20 |
|
|
 |
N-(1,3-ジヒドロ-1,3-ジオキソイソベンゾフラン-4-イル)アセトアミド |
6296-53-3 |
C10H7NO4 |
 |
3-エトキシ-4-メトキシ安息香酸 |
2651-55-0 |
C10H12O4 |
|
|
Apixaban IMpurity(BMS-591329-01) |
|
|
|
|
ApreMilast IMpurity |
|
|
 |
1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine |
1450657-31-4 |
C12H17NO4S |
|
|
Apremilast Impurity D |
|
|
|
|
Apixaban Impurity BMS-A |
|
|
|
|
Apremilast Impurity 6 |
|
|
 |
Apremilast |
1384439-80-8 |
C17H16N2O6S |
![(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine](/CAS/20150408/GIF/380499-06-9.gif) |
(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine |
380499-06-9 |
C20H18F7NO2 |
 |
2(1H)-Pyrimidinone,4-amino-1-b-D-arabinofuranosyl-, 3-oxide |
30902-36-4 |
C9H13N3O6 |
|
|
Aprepitant Impurity 16 |
850354-60-8 |
|
|
|
Aprepitant Impurity 35 |
|
|
 |
tert-butyl (3S,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
|
C37H43FN2O5 |
|
|
Aprepitant iMpurity 40 |
|
|
|
|
Aprepitant iMpurity43 |
|
|
 |
(3R,5R)-7-(2-(2-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
2243639-98-5 |
C33H37CaFN2O5 |
![2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1,1-Dimethylethyl Ester](/CAS/20210305/GIF/947262-20-6.gif) |
2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1,1-Dimethylethyl Ester |
947262-20-6 |
C37H41FN2O5 |
 |
アトルバスタチン環状(フルオロフェニル)ナトリウム塩不純物 |
1315629-79-8 |
C33H34FN2NaO7 |
![(2S,3R)-2-[(1S)-1-[3,5-ビス(トリフルオロメチル)フェニル]エトキシ]-3-(4-フルオロフェニル)モルホリン](/CAS/20150408/GIF/327623-37-0.gif) |
(2S,3R)-2-[(1S)-1-[3,5-ビス(トリフルオロメチル)フェニル]エトキシ]-3-(4-フルオロフェニル)モルホリン |
327623-37-0 |
C20H18F7NO2 |
![(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(phenyl)Morpholine hydrochloride](/CAS/20150408/GIF/874460-46-5.gif) |
(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(phenyl)Morpholine hydrochloride |
874460-46-5 |
C20H20ClF6NO2 |
|
|
Aprepitant iMpurity B |
|
|
|
|
Aprepitant Impurity 2 |
|
|
 |
5-Methylarabinosylcytosine |
6829-31-8 |
C10H15N3O5 |
![1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid](/CAS/20130318/GIF/CB82611222.gif) |
1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid |
1696392-11-6 |
C24H21N3O4 |
|
|
AtracuriuM IMpurity I (Mixture of cis, trans(I1), cis, cis(I2), tans, trans IsoMer) |
|
|
 |
Azilsartan Impurity |
1821386-21-3 |
C22H18N4O4 |
|
|
Atracurium Impurity 26 |
|
|
|
|
Apremilast Impurity SY |
|
|
|
|
Atracurium Impurity L |
|
|
|
|
NA |
|
|
|
|
AtracuriuM IMpurity C (Mixture of DiastereoMers) |
86293-35-8 |
|
|
|
AtracuriuM IMpurity E (cis-Quaternary Acid) |
|
|
 |
Aprepitant EP Impurity B |
2206606-86-0 |
C29H25F7N4O3 |
 |
Azilsartan Impurity 16 |
1417576-00-1 |
C28H20N4O8 |
|
|
Apixaban Impurity J |
|
|
|
|
Azithromycin EP Impurity K |
|
|
|
|
Apremilast Impurity QJ |
|
|
|
|
Apremilast Impurity TTN |
|
|
 |
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10,11,13- pentahydroxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6- azacyclopentadecan-15-one |
117693-42-2 |
C22H43NO7 |
|
|
Atracurium Impurity 31 |
|
|
|
|
AZITHROMYCIN IMPURITY A |
|
|
 |
Benzenemethanamine, α,α'-sulfonylbis(methylene)bis[3-ethoxy-4-methoxy- |
2417213-71-7 |
C22H32N2O6S |
|
|
Aprepitant impurity 2 |
|
|
|
|
Aprepitant impurity 4 |
|
|
|
|
Aprepitant Impurity 24 |
|
|
 |
Aprepitant |
1242175-38-7 |
C20H18F7NO2 |
|
|
Aprepitant Impurity 32 |
|
|
 |
Aprepitant Impurity 42 |
172678-47-6 |
C20H18F7NO2 |
 |
Nsc249004 |
7428-39-9 |
C9H13N3O5 |
 |
Atorvastatin Cyclic Isopropyl Impurity |
873950-17-5 |
C33H35FN2O7 |
 |
Difluoro Atorvastatin |
693794-20-6 |
C66H66CaF4N4O10 |
 |
(3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
|
C33H35FN2O5 |
 |
(1R,2S,3S)-Aprepitant |
172822-28-5 |
C23H21F7N4O3 |
 |
2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
929540-41-0 |
C36H41CaFN2O5 |
 |
(S,E)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxyhept-2-enoic acid calcium(II) |
1659317-57-3 |
C33H35CaFN2O4 |
 |
4-(オキシラニルメトキシ)ベンゼンアセトアミド |
29122-69-8 |
C11H13NO3 |
![1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, sodium salt (1:1), (4R,6R)-](/CAS/20211123/GIF/862260-38-6.gif) |
1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, sodium salt (1:1), (4R,6R)- |
862260-38-6 |
C36H40FN2NaO5 |
 |
Aprepitant iMpurity |
96730-04-0 |
C13H22NO4P |
 |
Aprepitant Impurity 17 |
1333998-27-8 |
C20H19ClF7NO2 |
![2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione](/CAS/20180528/GIF/1809464-27-4.gif) |
2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione |
1809464-27-4 |
C22H17ClO3 |
|
|
Aprepitant impurity C |
|
|
 |
C-Desmethyl Atenolol |
1797116-92-7 |
C13H20N2O3 |
![2-[4-(2,3-DIHYDROXYPROPOXY)PHENYL]ACETAMIDE](/CAS/GIF/61698-76-8.gif) |
2-[4-(2,3-DIHYDROXYPROPOXY)PHENYL]ACETAMIDE |
61698-76-8 |
C11H15NO4 |
![1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βS,δR)-](/CAS/20210305/GIF/2588261-38-3.gif) |
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βS,δR)- |
2588261-38-3 |
C37H43FN2O5 |
 |
4-アセトキシイソフタル酸 |
5985-26-2 |
C10H8O6 |
 |
(S)-2-((R)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-4-benzylMorpholin-3-one |
327623-36-9 |
C21H19F6NO3 |
![1-[2-[[(2R)-テトラヒドロ-4β-ヒドロキシ-6-オキソ-2H-ピラン]-2α-イル]エチル]-5-(4-フルオロフェニル)-2-イソプロピル-4,N-ジフェニル-1H-ピロール-3-カルボアミド](/CAS/GIF/125995-03-1.gif) |
1-[2-[[(2R)-テトラヒドロ-4β-ヒドロキシ-6-オキソ-2H-ピラン]-2α-イル]エチル]-5-(4-フルオロフェニル)-2-イソプロピル-4,N-ジフェニル-1H-ピロール-3-カルボアミド |
125995-03-1 |
C33H33FN2O4 |
 |
Aprepitant |
170902-80-4 |
C20H18F7NO2 |
 |
Aprepitant Impurity 33 |
502537-39-5 |
C20H20F7NO3 |
 |
Cytarabine Impurity 10 |
32830-01-6 |
C9H11N3O4 |
 |
Aprepitant Impurity 44 |
172676-88-9 |
C23H21F7N4O3 |
|
|
Aprepitant iMpurity 37 |
|
|
 |
(2Z)-2,3-Dehydroxy Atorvastatin (>90% Z) |
1191901-60-6 |
C33H33FN2O4 |
![[2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine](/CAS/GIF/170729-79-0.gif) |
[2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine |
170729-79-0 |
C20H18F7NO2 |
 |
Atorvastatin Lactam Impurity |
906552-18-9 |
C33H35FN2O6 |
 |
2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid
(Diketopiperazine) |
|
C29H42N8O18S4 |
![(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole](/CAS/20210111/GIF/65576-39-8.gif) |
(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole |
65576-39-8 |
C17H17NO |
 |
(1R,2S,3R)-Aprepitant |
1185502-97-9 |
C23H21F7N4O3 |
 |
Aprepitant Impurity 22 |
934540-48-4 |
C20H16F7NO2 |
 |
Aprepitant Impurity 9 |
219821-37-1 |
C24H25F7N4O4 |
|
|
Aprepitant Impurity 28 |
|
|
 |
(3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
1428118-12-0 |
C37H43FN2O5 |
|
|
Aprepitant Impurity 53 |
|
|
 |
亜りん酸トリベンジル |
15205-57-9 |
C21H21O3P |
 |
1-(2-O,3-O,5-O-トリアセチル-β-D-アラビノフラノシル)-2,4(1H,3H)-ピリミジンジオン |
14057-18-2 |
C15H18N2O9 |
 |
Reaxys ID: 3623864 |
129385-61-1 |
C17H10ClNO3 |
 |
(1S,2S,3S)-Aprepitant |
1242175-40-1 |
C23H21F7N4O3 |
|
|
Aprepitant Impurity 3 |
|
|
 |
Aprepitant Impurity 12 |
172673-23-3 |
C23H21F7N4O4 |
|
|
Aprepitant Impurity 18 |
|
|